Caleb L Carlsen

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Squamous Cell Carcinoma

Induced Apoptosis

Top Venues

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

John B Tucker, Caleb L Carlsen, Christina M Scribano, Srishrika M Pattaswamy, Mark E Burkard, Beth A Weaver
CENP-E Inhibition Induces Chromosomal Instability and Synergizes with Diverse Microtubule-Targeting Agents in Breast Cancer. Cancer research 84 (16) (2024)
John B Tucker, Caleb L Carlsen, Christina M Scribano, Srishrika M Pattaswamy, Mark E Burkard, Beth A Weaver
CENP-E inhibition induces chromosomal instability and synergizes with diverse microtubule-targeting agents in breast cancer. Cancer research (2024)
John B Tucker, Caleb L Carlsen, Christina M Scribano, Srishrika M Pattaswamy, Mark E Burkard, Beth A Weaver
CENP-E inhibition induces chromosomal instability and synergizes with diverse microtubule-targeting agents in breast cancer. Cancer research (2024)
John B Tucker, Caleb L Carlsen, Christina M Scribano, Srishrika M Pattaswamy, Mark E Burkard, Beth A Weaver
CENP-E inhibition induces chromosomal instability and synergizes with diverse microtubule-targeting agents in breast cancer. Cancer research (2024)
John B Tucker, Caleb L Carlsen, Christina M Scribano, Srishrika M Pattaswamy, Mark E Burkard, Beth A Weaver
CENP-E Inhibition Induces Chromosomal Instability and Synergizes with Diverse Microtubule-Targeting Agents in Breast Cancer. Cancer research 84 (16) (2024)
John B Tucker, Caleb L Carlsen, Christina M Scribano, Srishrika M Pattaswamy, Mark E Burkard, Beth A Weaver
CENP-E Inhibition Induces Chromosomal Instability and Synergizes with Diverse Microtubule-Targeting Agents in Breast Cancer. Cancer research 84 (16) (2024)
John B Tucker, Caleb L Carlsen, Christina M Scribano, Srishrika M Pattaswamy, Mark E Burkard, Beth A Weaver
CENP-E inhibition induces chromosomal instability and synergizes with diverse microtubule-targeting agents in breast cancer. Cancer research (2024)